Kenvue & American College of Obstetricians and Gynecologists

Kenvue: Kenvue, the maker of Tylenol, disputed any link between the drug and autism. Its shares fell 7.5% in trading, reducing its market value by about $2.6 billion due to Donald Trump's statements.

American College of Obstetricians and Gynecologists: The American College of Obstetricians and Gynecologists stated that suggestions linking Tylenol to autism are irresponsible, highlighting the harmful message to pregnant patients.

Kenvue: Kenvue, the manufacturer of Tylenol, strongly disagreed with the suggestion that acetaminophen causes autism, defending the drug's safety and warning of risks from untreated fever or pain.

American College of Obstetricians and Gynecologists: The American College of Obstetricians and Gynecologists contradicted the new FDA guidance, maintaining that acetaminophen is generally safe during pregnancy and criticizing the lack of scientific backing for the administration's announcement.

Kenvue: Kenvue, the manufacturer of Tylenol, refuted the claims made by Robert F. Kennedy Jr. and Donald Trump, stating that studies have found no causal link between acetaminophen use during pregnancy and fetal developmental issues.

American College of Obstetricians and Gynecologists: The American College of Obstetricians and Gynecologists endorsed the use of acetaminophen during pregnancy and criticized the claims made by Robert F. Kennedy Jr. and Donald Trump as irresponsible and not backed by scientific evidence.

Kenvue: Kenvue, a spin-off of Johnson & Johnson, is a primary defendant in the United States — Texas lawsuit, accused of deceptively marketing Tylenol and facing claims of liability transfer from Johnson & Johnson. Kenvue's shares fell following the news.

American College of Obstetricians and Gynecologists: The American College of Obstetricians and Gynecologists has defended the safety of acetaminophen during pregnancy, calling claims of an autism link irresponsible.

Kenvue: Kenvue, the manufacturer of Tylenol (paracetamol), faced a lawsuit regarding alleged links between its product and autism, which was dismissed. The new study supports the safety of its product.